OakChart

SS Innovations International Inc

SSIIHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 11:53 AM ET

1.55-0.06 (-3.42%)
2026-11-11 17:56 CET
Market cap
322.77 USD m
Revenue, TTM
52.34 USD m
Net income, TTM
-12.43 USD m
Free cash flow, TTM
-18.22 USD m
EPS diluted, TTM
-0.06
P/E
-
Compare

Price

SSII against its 20, 50 and 200-day averages
2050200earnings
2.003.004.005.006.00129K258KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SSIIclose 1.5620-day 2.2650-day 2.72200-day 3.741.56

78.2% under the 52-week high of 7.13 on 11 Nov 2025. 52-week low 1.44 on 10 Nov 2026. Last 15 sessions, 85.4% high to low

Profile

SSII
52-week range, 2% of the way up
1.447.13

SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. Its proprietary software integrates Artificial Intelligence (AI) and Deep Learning, or machine learning (DL). It focuses on research and development to an AI-enhanced robotics platform system that can be combined with proven medical devices, end-effectors, and surgical instruments. The company was founded by Sudhir Prem Srivastava and Barry F. Cohen on February 4, 2015 and is headquartered in Fort Lauderdale, FL.

Employees483
IPOOct 17, 2018
Beta-106.80
ATR, 14d0.29
Rel volume1.06
Short float0.16%
Insider own80.37%
Inst own1.03%

Snapshot

6 groups

Valuation

Index-
Market Cap311.74M
Enterprise Value307.31M
Income-12.43M
Sales52.34M
Book/sh0.27
Cash/sh0.11
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees483
IPOOct 17, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S5.96
P/B5.83
P/C13.98
P/FCF-
EV/EBITDA-
EV/Sales5.87
Quick Ratio1.66
Current Ratio2.24
Debt/Eq0.33
LT Debt/Eq0.05
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.06
EPS next Y-0.06
EPS next Q-0.01
EPS this Y0.00%
EPS next Y0.00%
EPS next 5Y44.97%
EPS past 3/5Y36.64% 33.24%
Sales past 3/5Y209.10% -
EPS Y/Y TTM-0.32%
Sales Y/Y TTM89.98%
EPS Q/Q-923.08%
Sales Q/Q39.48%
EarningsAug 13 BMO
EPS/Sales Surpr.0.00% 16.16%

Ownership

Insider Own80.37%
Insider Trans-0.02%
Inst Own1.03%
Inst Trans2.53%
ROA-14.89%
ROE-26.06%
ROIC-22.22%
Gross Margin45.14%
Oper. Margin-16.24%
Profit Margin-23.76%
SMA20-31.08%
SMA50-42.84%
SMA200-58.47%
Trades-

Technical

Shs Outstand200.17M
Shs Float39.35M
Short Float0.16%
Short Ratio1.03
Short Interest0.06M
52W High7.13 -78.19%
52W Low1.44 7.99%
Volatility28.62% 14.62%
ATR (14)0.29
RSI (14)24.42
Beta-106.80
Rel Volume1.06
Avg Volume62.42K
Volume26,730

Performance

Perf Week-31.50%
Perf Month-39.02%
Perf Quarter-59.40%
Perf Half Y-61.03%
Perf YTD-72.62%
Perf Year-76.93%
Perf 3Y-74.08%
Perf 5Y19.62%
Perf 10Y-
Recom1.00
Target Price7.00
Prev Close1.61
Price1.55
Change %-3.42%

Peers

Mkt cap
TickerCompanyMkt cap
ISRGIntuitive Surgical Inc154.60B
MDTMedtronic Plc129.34B
MBOTMicrobot Medical Inc74.17M
PRCTProcept BioRobotics Corp1.33B
SYKStryker Corp121.05B
CLPTClearPoint Neuro Inc290.74M
ZBHZimmer Biomet Holdings Inc20.13B
GMEDGlobus Medical Inc9.87B
PROFProfound Medical Corp287.55M
STXSStereotaxis Inc86.72M

Insider trading

4 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Sudhir SrivastavaChairman and CEOSep 04 '26Sale3.0033,33399,999108,520,928Sep 09 09:39 PM
MOLL FREDERIC HDirectorMar 06 '26Buy3.99501,2531,999,99910,775,485Mar 10 06:05 PM
Adams Timothy P.DirectorMar 06 '26Buy3.99300,0001,197,0005,331,902Mar 10 06:04 PM
Sudhir SrivastavaChairman and CEOMar 06 '26Buy4.01498,7532,000,000109,851,767Mar 10 06:03 PM

Held by

AUM
TickerCompanyAUM
ISMDInspire Small/Mid Cap ETFAUM: 330.79M

News

latest 14 of 150
  • SS Innovations International (SSII) CEO Outlines Growth Strategy as SSi Mantra Expands Robotic Surgery, Telesurgery, and Global Reach (NewMediaWire) +11.05%
  • SS Innovations International (SSII) Demonstrates Long-Distance Robotic Cardiac Surgery at Industry Events (NewMediaWire)
  • SS Innovations International (SSII) Showcases Robotic Telesurgery Capabilities at International Medical Conferences (NewMediaWire) +5.33%
  • SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences (GlobeNewswire)
  • SS Innovations International (SSII) Submits FDA Response for SSi Mantra Surgical Robotic System (NewMediaWire) +5.88%
  • Loading…
  • SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company's 510(k) Submission for the SSi Mantra (GlobeNewswire)
  • 2 International Microcaps for Your Watchlist (Zacks)
  • SS Innovations International(SSII) Builds Telerobotic Surgery Position as Remote Procedures Gain Ground (NewMediaWire)
  • SS Innovations International (SSII) Expands Robotic Cardiac Surgery Footprint With New Program at HCG Hospital in Ahmedabad (NewMediaWire)
  • SS Innovations International (SSII) Expands Global Footprint as SSi Mantra Procedures Reach 14,103 (NewMediaWire)
  • SS Innovations International (SSII) Brings Robotic Cardiac Surgery to Sri Lanka (NewMediaWire)
  • SS Innovations International (SSII) Reports 79% Growth in SSi Mantra Procedures, Expands Global Reach (NewMediaWire)
  • SS Innovations Provides Update on Continuing Progress and Milestones (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-13-0.010-0.010-0.01013.9412.001
2026Q12026-06-03-0.020-0.020-0.01811.0011.001
2025Q42026-03-10---0.01014.53--
2025Q32025-10-28---0.02012.83--
2025Q22025-08-07--0.00010.00--
2025Q12025-05-14---0.0305.12--
2026Q3---0.010--15.101
2026Q4---0.010--19.501
2027Q1---0.010--15.401
2027Q2---0.010--17.401
2027Q3---0.020--20.401
2027Q4---0.020--23.001
2028Q1---0.010--21.701
2028Q2--0.000--24.801
2028Q3--0.000--26.401
2028Q4--0.010--30.501

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-0.060--0.06043.00-
2026FY--0.060--59.60
2027FY--0.060--76.20
2028FY--0.010--103.4

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-2710015.1015.1015.10
2026Q3S2026-08-2611015.1015.1015.10
2026Q3S2026-08-1311015.0015.0015.00
2026Q3S2026-06-0310014.0014.0014.00
2026Q3S2026-06-0210014.0014.0014.00
2026Q3R2026-08-13100-0.01-0.01-0.01
2026Q3R2026-06-03100-0.01-0.01-0.01
2026Q3R2026-06-02100-0.01-0.01-0.01
2026Q3E2026-08-13100-0.01-0.01-0.01
2026Q3E2026-06-03100-0.01-0.01-0.01
2026Q3E2026-06-02100-0.01-0.01-0.01
2026Q2S2026-06-0310012.0012.0012.00
2026Q2S2026-06-0210012.0012.0012.00
2026Q2R2026-06-03100-0.01-0.01-0.01

Estimate history

EPS, annual-0.5-0.46-1.572-0.481-0.521-0.251-0.144-0.112-0.064-0.0635
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.024-0.019-0.011-0.032-0.001-0.019-0.013-0.018-0.013
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual000001.4365.87520.57842.41452.34
Period201720182019202020212022202320242025TTM
Sales, quarterly4.5094.3668.0985.1029.98212.80414.52511.08413.924
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual2.0642.1012.1862.6014.21112.816170.712171.579194.165200.169
Period201720182019202020212022202320242025MRQ
Shares, quarterly170.739170.864171.579193.556193.588193.592194.165200.132200.169
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue52.3442.4120.585.881.440.000.000.000.00
Cost of Goods Sold Incl. D&A28.7124.0212.635.301.470.020.040.040.02
Gross Profit23.6318.407.940.57-0.04-0.02-0.04-0.04-0.02
Selling, General and Administrative Excl. Other32.1326.5526.9920.852.921.391.073.280.94
Research and Development5.573.692.491.060.990.000.000.060.03
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-8.50-8.15-19.05-20.27-2.96-1.41-1.10-3.32-0.96
Interest Expense1.141.110.970.890.27-0.000.02-
Unusual Expense0.000.000.000.000.000.00-0.000.04-
Net Income Before Taxes-8.16-8.16-19.15-20.88-3.21-1.48-1.12-3.39-0.96
Income Taxes4.273.970.000.000.000.000.000.000.00
Consolidated Net Income-12.43-12.13-19.15-20.88-3.21-1.48-1.12-3.39-0.96
Net Income From Continuing Operations-12.43-12.13-19.15-20.88-3.21-1.48-1.12-3.39-0.96
Net Income-12.43-12.13-19.15-20.88-3.21-1.48-1.12-3.39-0.96
EPS (Recurring)-0.06-0.06-0.11-0.14-0.25-0.52-0.48-1.56-0.46
EPS (Basic, Before Extraordinaries)-0.06-0.06-0.11-0.14-0.25-0.52-0.48-1.57-0.46
EPS (Diluted)-0.06-0.06-0.11-0.14-0.25-0.52-0.48-1.57-0.46
EBITDA-7.22-7.08-18.61-20.12-2.86-1.39-1.07-3.28-0.94
Non-Operating Income (Expense)1.481.100.870.290.01-0.08-0.037E-060.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.466.4214.349.720.000.950.811.090.19
Price To Sales Ratio15.8725.4565.51178.7690.13----
Gross Margin45.1443.3838.619.75-2.51----
Operating Margin-16.24-19.22-92.56-345.07-206.01----
Net Margin-23.76-28.59-93.07-355.36-223.79----
Shares Outstanding200.17194.17171.58170.7112.824.212.602.192.10
Market Capitalization322.77322.771,348.121,226.1145.610.0311.6021.8662.81

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue13.9211.0814.5312.809.985.108.104.37
Cost of Goods Sold Incl. D&A7.196.108.476.964.354.244.292.19
Gross Profit6.744.996.065.845.640.863.802.18
Selling, General and Administrative Excl. Other9.038.646.767.705.566.805.665.40
Research and Development2.401.001.390.790.501.010.760.44
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.29-3.66-0.70-1.860.08-5.94-1.86-3.23
Interest Expense0.340.280.340.180.220.380.290.25
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-2.16-3.43-0.71-1.870.10-5.68-1.92-3.25
Income Taxes0.510.151.771.850.350.000.000.00
Consolidated Net Income-2.66-3.58-2.47-3.72-0.26-5.68-1.92-3.25
Net Income From Continuing Operations-2.66-3.58-2.47-3.72-0.26-5.68-1.92-3.25
Net Income-2.66-3.58-2.47-3.72-0.26-5.68-1.92-3.25
EPS (Recurring)-0.01-0.02-0.01-0.02-0.00-0.03-0.01-0.02
EPS (Basic, Before Extraordinaries)-0.01-0.02-0.01-0.02-0.00-0.03-0.01-0.02
EPS (Diluted)-0.01-0.02-0.01-0.02-0.00-0.03-0.01-0.02
EBITDA-1.94-3.33-0.39-1.560.34-5.73-1.71-3.11
Non-Operating Income (Expense)0.480.510.330.170.230.640.230.23
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.722.481.601.661.292.382.342.45
Price To Sales Ratio15.8720.2526.0034.9741.3981.0165.6849.25
Gross Margin48.4044.9941.7145.6356.4716.8546.9949.87
Operating Margin-16.43-32.98-4.81-14.530.79-116.43-22.93-73.88
Net Margin-19.11-32.32-17.01-29.04-2.57-111.35-23.75-74.34
Shares Outstanding200.17200.13194.17193.59193.59193.56171.58170.86
Market Capitalization322.77971.781,099.771,258.321,140.331,877.451,348.12682.96

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments9.146.317.050.270.410.160.030.040.45
Short Term Receivables18.027.163.812.490.000.000.000.000.00
Inventories17.0610.217.020.900.000.000.000.000.00
Other Current Assets4.573.753.550.420.000.000.010.010.01
Total Current Assets48.8027.4221.434.100.410.160.030.040.46
Net Property, Plant & Equipment11.858.013.361.920.020.040.080.040.00
Total Investments and Advances0.460.320.040.000.000.120.000.000.00
Long-Term Note Receivable8.573.302.370.89-----
Intangible Assets---0.000.000.000.010.070.04
Deferred Tax Assets0.72--------
Other Assets4.013.344.320.080.000.000.000.000.00
Total Assets74.4142.3931.526.980.430.320.130.150.51
Short Term Debt Incl. Current Port. of LT Debt12.0215.856.936.430.140.200.460.010.00
Accounts Payable5.132.310.900.170.120.130.140.010.00
Other Current Liabilities9.093.160.651.170.020.860.600.420.41
Total Current Liabilities26.2421.338.477.770.291.191.200.450.41
Long Term Debt2.342.352.351.840.000.000.000.000.00
Provision for Risks Charges0.190.070.030.010.000.000.000.000.00
Deferred Tax Liabilities0.19--------
Other Liabilities7.245.170.940.040.000.000.000.000.00
Total Liabilities36.1928.9311.809.660.291.191.200.450.41
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value1E-061E-061E-060.000.000.000.000.000.00
Common Equity38.2213.4619.72-2.680.14-0.87-1.06-0.300.10
Total Shareholders Equity38.2213.4619.72-2.680.14-0.87-1.06-0.300.10
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity38.2213.4619.72-2.680.14-0.87-1.06-0.300.10
Total Liabilities & Stockholders Equity74.4142.3931.526.980.430.320.130.150.51
Book Value Per Share0.200.080.12-0.210.03-0.33-0.49-0.140.05
Tangible Book Value Per Share0.200.080.12-0.210.03-0.33-0.49-0.180.03
Full-Time Employees483378239510101066
Price to Book Ratio6.0397.0577.78137.120.24-13.35-20.56-206.38-236.29
Return on Assets-20.77-51.83-108.47-86.75-397.68-499.42-2,436.32-293.05-258.72
Return on Equity-46.94-115.45-245.06-958.97-----
Return on Invested Capital-29.90-121.16-94.60--1,050.28----1,026.50
Quick Ratio1.210.811.700.411.420.140.030.091.13
Current Ratio1.861.292.530.531.420.140.030.091.13

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-12.43-12.13-19.15-20.88-3.21-1.48-1.12-3.39-0.96
Depreciation1.281.080.440.150.100.020.040.040.02
Other Funds (Non Cash)10.548.8216.0015.550.291.950.452.550.19
Funds from Operations-1.47-2.75-2.72-5.18-2.830.49-0.63-0.80-0.75
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-14.07-15.79-6.79-10.18-3.16-0.850.540.370.31
Income Taxes Payable4.534.21-------
Cash from Operating Activities-15.53-18.54-9.50-15.36-5.99-0.36-0.09-0.42-0.44
Capital Expenditures-2.68-3.66-0.66-0.450.000.00-0.00-0.05-0.02
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.240.040.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.00-0.040.000.00
Purchase of Investments0.000.000.000.000.000.00-0.040.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-2.68-3.66-0.66-0.450.240.04-0.04-0.05-0.02
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.410.000.540.200.040.02
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.410.000.540.200.040.02
Proceedsfrom Stock Options0.000.000.000.000.000.530.190.000.02
Issuance or Reduction of Debt, Net26.1026.179.4322.335.900.000.070.430.03
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.050.000.030.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities26.1026.179.4322.805.900.570.270.470.05
Exchange Rate Effect-2.82-0.990.27-0.170.04----
Net Change in Cash5.072.98-0.466.810.190.250.13-0.01-0.42
Free Cash Flow-18.22-22.20-10.16-15.81-1.44-0.36-0.09-0.47-0.45
Preferred Dividends (Cash Flow)----0.000.000.000.000.00
Deferred Taxes & Investment Tax Credit--0.510.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments22.3023.619.1411.7117.2621.76
Short Term Receivables23.8319.8718.0212.0010.748.04
Inventories18.4817.0717.0620.0418.2614.30
Other Current Assets6.845.724.574.684.533.52
Total Current Assets71.4566.2648.8048.4250.7947.62
Net Property, Plant & Equipment11.6811.3311.8510.7110.939.67
Total Investments and Advances0.380.390.460.330.350.32
Deferred Tax Assets0.840.810.720.160.37-
Other Assets4.124.494.013.033.103.03
Total Assets96.9890.5574.4169.5869.9863.46
Short Term Debt Incl. Current Port. of LT Debt15.3211.7312.0210.417.338.05
Accounts Payable5.274.405.134.666.083.64
Income Tax Payable----0.62-
Other Current Liabilities11.309.919.096.125.583.30
Total Current Liabilities31.8926.0526.2421.1919.6115.00
Long Term Debt2.552.092.342.272.452.40
Provision for Risks Charges0.240.190.190.120.110.10
Deferred Tax Liabilities--0.19---
Other Liabilities8.907.707.246.355.785.41
Total Liabilities43.5836.0236.1929.9327.9522.90
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value1E-061E-061E-061E-061E-061E-06
Common Equity53.4054.5238.2239.6542.0240.55
Total Shareholders Equity53.4054.5238.2239.6542.0240.55
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity53.4054.5238.2239.6542.0240.55
Total Liabilities & Stockholders Equity96.9890.5574.4169.5869.9863.46
Book Value Per Share0.270.270.200.200.220.21
Tangible Book Value Per Share0.270.270.200.200.220.21
Full-Time Employees--483---
Price to Book Ratio6.0325.4027.7329.9428.11124.81
Return on Assets-14.89-13.02-20.77-21.33-21.03-30.39
Return on Equity-26.06-21.10-46.94-43.42-39.11-52.32
Return on Invested Capital-4.76-6.33-6.09-8.87-0.58-13.23
Quick Ratio1.661.891.211.341.662.22
Current Ratio2.242.541.862.292.593.18

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-2.66-3.58-2.47-3.72-0.26-5.68
Depreciation0.350.320.310.300.260.21
Other Funds (Non Cash)2.183.222.152.991.502.18
Funds from Operations-0.17-0.34-0.52-0.441.51-3.30
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-4.07-1.97-1.00-7.03-4.96-2.81
Income Taxes Payable0.610.322.021.57--
Cash from Operating Activities-4.23-2.31-1.52-7.47-3.45-6.10
Capital Expenditures-0.16-0.05-1.71-0.76-0.32-0.87
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.16-0.05-1.71-0.76-0.32-0.87
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)---0.00--
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net3.4818.161.373.09-0.7022.41
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities3.4818.161.373.09-0.7022.41
Exchange Rate Effect-0.42-1.39-0.58-0.43-0.000.03
Net Change in Cash-1.3314.40-2.44-5.57-4.4715.46
Free Cash Flow-4.40-2.37-3.23-8.22-3.77-6.98

Revenue breakdown

Instruments Sale2024: 942.55K 2025: 3.18M
Lease Income2024: 71.70K 2025: 70.91K
System Sales2024: 19.46M 2025: 38.35M
Warranty Sale2024: 177.52K 2025: 877.03K
Cyprus2025: 522.33K
IRAQ2025: 766.26K
India2024: 19.08M 2025: 36.79M
Indonesia2024: 595.90K 2025: 1.02M
NEPAL2024: 501.72K 2025: 18.71K
Oman2025: 85.38K
Philippines2025: 2.25M
South America2024: 468.20K 2025: 1.01M
United Arab Emirates2025: 31.26K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.16%0.1M39.4M56.27K
2026-10-150.18%0.1M39.4M62.87K
2026-09-300.17%0.1M39.2M63.98K
2026-09-150.15%0.1M39.2M60.69K
2026-08-310.19%0.1M39.0M63.55K
2026-08-140.17%0.1M39.0M65.98K
2026-07-310.21%0.1M37.5M67.33K
2026-07-150.35%0.1M37.5M57.93K
2026-06-300.13%0.0M37.5M55.49K
2026-06-150.14%0.1M37.5M52.96K
2026-05-290.14%0.1M37.5M53.65K
2026-05-150.15%0.1M37.5M55.69K
2026-04-300.15%0.0M32.6M79.52K
2026-04-150.23%0.1M32.6M90.15K
2026-03-310.45%0.1M33.0M94.59K
2026-03-130.67%0.2M32.0M99.24K
2026-02-270.78%0.2M31.9M100.45K
2026-02-130.87%0.3M31.9M100.65K
2026-01-300.46%0.1M31.9M79.64K
2026-01-150.30%0.1M32.0M84.25K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-268-KCurrent report2026-10-26SEC
2026-10-138-KCurrent report2026-10-13SEC
2026-10-138-KCurrent report2026-10-09SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-09424B5SEC
2026-10-058-KCurrent report2026-10-05SEC
2026-09-108-KCurrent report2026-09-10SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-08-268-KCurrent report2026-08-21SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-043Initial statement of beneficial ownership of securities2026-08-03SEC
2026-07-178-KCurrent report2026-07-17SEC
2026-07-148-KCurrent report2026-07-14SEC
2026-07-078-KCurrent report2026-07-07SEC
2026-06-308-KCurrent report2026-06-30SEC
2026-06-188-KCurrent report2026-06-18SEC
2026-06-18424B5SEC
2026-06-158-KCurrent report2026-06-15SEC
2026-06-08S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-048-KCurrent report2026-06-04SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-05-268-KCurrent report2026-05-18SEC
2026-05-20424B5SEC
2026-05-18EFFECTEffectiveness filing by commission orderSEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-13CORRESPSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0900100.00K1
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-035.20M300
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Hood River Capital Management LLC0.42%
Inspire Investing, LLC0.11%
71 West Capital Partners0.10%
SAGESPRING WEALTH PARTNERS, LLC0.07%
Handelsbanken Fonder AB0.06%
Eversept Partners, LP0.06%
JNBA Financial Advisors0.05%
AlphaCentric Advisors LLC0.02%
GEODE CAPITAL MANAGEMENT, LLC0.02%
Forum Financial Management, LP0.02%

Funds

Fund% owned
Hood River International Opportunity Fund0.42%
Inspire Small/Mid Cap ETF0.09%
AlphaCentric Robotics and Automation Fund0.02%
Fidelity Nasdaq Composite Index Fund0.02%
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF0.01%
Goldman Sachs Absolute Return Tracker Fund0.00%
TIFF MULTI-ASSET FUND0.00%
Knights of Columbus U.S. ALL CAP INDEX FUND0.00%

OakChart. SSII. Cached 15 minutes.

Some panels did not load: ratings.